InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Olagunju Peter. Director active across 1 company, notably TCR2 THERAPEUTICS INC.. Aggregated, 5 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €5k. History available since 5 December 2022. The latest transaction was filed on 9 December 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
5 of 5 declarations